Abstract 4365029: Temporal Association and Prognosis of Atrial Fibrillation/Flutter with Heart Failure and its Subtypes in Post-menopausal Women: A Women’s Health Initiative Study

Introduction: Heart failure (HF) and atrial fibrillation/flutter (AF) often co-occur in older adults. Understanding the temporal relationship of HF and its subtypes (HFpEF and HFrEF) with AF and their prognosis are understudied and was the objective herein. Methods: This prospective cohort study included 31,171 post-menopausal women from the Women’s Health Initiative (WHI) study with adjudicated HF outcomes, merged with Medicare database for adjudicated AF outcomes during a median follow-up of 17 years. Participants were categorized into 4 groups: No incident AF or HF (n=22578); incident AF (n=6466); incident HF (n=1004); and both incident AF-HF (n=1123). Cox proportional hazards regression analysis was performed to study temporal association between AF and HF, all-cause and cardiovascular death (CVD). Results: Participants had a mean age of 63.2 (6.9) years at baseline. The risk of all-cause and CVD related death was elevated in incident AF [all-cause death HR 95% CI: 1.15 (1.08, 1.21); CVD death HR 95% CI: 1.32 (1.17, 1.50)], incident HF [All-cause death HR 95% CI: 1.84 (1.69, 2.01); CVD death HR 95% CI: 3.43 (2.94, 4.00)], and incident AF-HF [All-cause death HR 95% CI: 1.72 (1.59, 1.87); CVD death HR 95% CI: 3.57 (3.12, 4.10)] compared to no AF or HF. Risk of developing incident HFpEF [HR, 95% CI: 2.03 (1.77, 2.32)] and incident HFrEF [HR, 95% CI 1.33 (1.12, 1.59)] was higher with prior AF development compared to no prior AF. Conclusion: All-cause and CVD mortality is elevated with development of new AF, however mortality is much higher with incident HF or HF co-occurrence with AF. Risk of both HFpEF and HFrEF is elevated with presence of AF, with risk much higher for HFpEF in post-menopausal women. These findings underscore the importance of early detection and treatment of AF in post-menopausal women which can help reduce HF incidence and thereby overall mortality.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4365029
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4365029: Temporal Association and Prognosis of Atrial Fibrillation/Flutter with Heart Failure and its Subtypes in Post-menopausal Women: A Women’s Health Initiative Study

Miremad Moafi-Madani, Joseph C. Larson, Mary B. Roberts, Michael J. LaMonte et al.
Circulation
Atrial Fibrillation Management and Outcomes
article

Abstract 4365029: Temporal Association and Prognosis of Atrial Fibrillation/Flutter with Heart Failure and its Subtypes in Post-menopausal Women: A Women’s Health Initiative Study

Miremad Moafi-Madani, Joseph C. Larson, Mary B. Roberts, Michael J. LaMonte, Charles B. Eaton, Muhammad Baig, Nishant R. Shah, Muhammad Zain Ali, Ali Khan
article en

Abstract

Introduction: Heart failure (HF) and atrial fibrillation/flutter (AF) often co-occur in older adults. Understanding the temporal relationship of HF and its subtypes (HFpEF and HFrEF) with AF and their prognosis are understudied and was the objective herein. Methods: This prospective cohort study included 31,171 post-menopausal women from the Women’s Health Initiative (WHI) study with adjudicated HF outcomes, merged with Medicare database for adjudicated AF outcomes during a median follow-up of 17 years. Participants were categorized into 4 groups: No incident AF or HF (n=22578); incident AF (n=6466); incident HF (n=1004); and both incident AF-HF (n=1123). Cox proportional hazards regression analysis was performed to study temporal association between AF and HF, all-cause and cardiovascular death (CVD). Results: Participants had a mean age of 63.2 (6.9) years at baseline. The risk of all-cause and CVD related death was elevated in incident AF [all-cause death HR 95% CI: 1.15 (1.08, 1.21); CVD death HR 95% CI: 1.32 (1.17, 1.50)], incident HF [All-cause death HR 95% CI: 1.84 (1.69, 2.01); CVD death HR 95% CI: 3.43 (2.94, 4.00)], and incident AF-HF [All-cause death HR 95% CI: 1.72 (1.59, 1.87); CVD death HR 95% CI: 3.57 (3.12, 4.10)] compared to no AF or HF. Risk of developing incident HFpEF [HR, 95% CI: 2.03 (1.77, 2.32)] and incident HFrEF [HR, 95% CI 1.33 (1.12, 1.59)] was higher with prior AF development compared to no prior AF. Conclusion: All-cause and CVD mortality is elevated with development of new AF, however mortality is much higher with incident HF or HF co-occurrence with AF. Risk of both HFpEF and HFrEF is elevated with presence of AF, with risk much higher for HFpEF in post-menopausal women. These findings underscore the importance of early detection and treatment of AF in post-menopausal women which can help reduce HF incidence and thereby overall mortality.

CirculationVol. 152(Suppl_3)
Brown University (US), Warren Alpert Foundation (US), National Heart, Lung, and Blood Institute (US), University at Buffalo, State University of New York (US)
Openalex Percentile: Top 52%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.